Apoferritin/Vandetanib Association Is Long-Term Stable But Does Not Improve Pharmacological Properties of Vandetanib

A tyrosine kinase inhibitor, vandetanib (Van), is an anticancer drug affecting the signaling of VEGFR, EGFR and RET protooncogenes. Van is primarily used for the treatment of advanced or metastatic medullary thyroid cancer; however, its usage is significantly limited by side effects, particularly ca...

Descripción completa

Detalles Bibliográficos
Autores principales: Jáklová, Kateřina, Feglarová, Tereza, Rex, Simona, Heger, Zbyněk, Eckschlager, Tomáš, Hraběta, Jan, Hodek, Petr, Kolárik, Matúš, Indra, Radek
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8074211/
https://www.ncbi.nlm.nih.gov/pubmed/33923880
http://dx.doi.org/10.3390/ijms22084250

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8074211/
https://www.ncbi.nlm.nih.gov/pubmed/33923880
http://dx.doi.org/10.3390/ijms22084250

Ejemplares similares